Enrico Fazzini, D.O., Ph.D. is a neurologist and an osteopathic physician. He is considered an expert on Parkinson's disease and has published numerous research publications on the subject. He has been involved in a number of clinical trials for new pharmaceutical treatments for Parkinson's disease. He attended the University of Osteopathic Medicine and Health Sciences in Des Moines, Iowa. He is board certified in neurology by both the M.D. and D.O. medical boards. He began his practice in 1989. He has a clinical reputation for very intensive medication adjustments particularly using levodopa/carbidopa in small dosage increments to modulate Parkinson's symptoms. Dr. Enrico Fazzini completed his neurology training at Boston University in 1987 and his fellowship in Movement Disorders at Columbia Presbyterian in 1989 where he was instrumental in the development of botulinum toxin type A for use in dystonia. In addition to being a neurologist, Dr. Fazzini has a Ph.D. in Behavioral Neuroscience from Boston University and is an expert on the diagnosis and treatment of patients with traumatic brain injuries.
Dr. Fazzini was consulted by the Vatican for the treatment of John Paul II. He confirmed the competency of then Attorney-General Janet Reno after she was diagnosed with Parkinson's Disease. He helped to develop the Silverman speech therapy program for the treatment of Parkinson's Disease.
Dr. Fazzini's publications are listed on PubMed. Dr. Fazzini is credited with reintroducing surgical therapies utilized in the treatment of Parkinson's disease. He currently has one of the largest Parkinson's disease practices in the United States.
- "Enrico A. Fazzini, DO, PhD". WebMD. Retrieved 25 August 2012.
- "Enrico Fazzini, D.O., Ph.D". NYU Langone Medical Center. Retrieved 25 August 2012.
- ""Fazzini E"[Author] - PubMed - NCBI". Ncbi.nlm.nih.gov. 2012-05-24. Retrieved 2012-08-24.
- "Research Summary". NYU Langone Medical Center. Retrieved 4 October 2012.